• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

65
27
22
22
11

COUNTRY

22
3
2
1
1

PRICE

27
35
60
175

PUBLISHED

3
7
35
175

PRODUCT TYPE

166
9

Drug Delivery

Drug delivery systems include inhalers, injectors and infusion pumps; it is a sector of the pharmaceutical industry with tremendous growth prospects.

Browse Research and Markets’ Drug Delivery category to explore all aspects of this technology-driven industry, whether according to method of delivery (e.g. oral, intranasal, transdermal), affliction (e.g. diabetes, allergies, inflammation), or specific areas such as paediatric drug delivery, self-administration and drug safety.

Our reports, books and subscription cover every conceivable aspect of this industry, including the latest industry activity in specific countries and regions (North America, Europe, Asia, etc.) and key information on leading players such as Valeant Pharmaceuticals, Elan Corporation, PetMed Express, Hospira, and many more. Show Less Read more

PRODUCT TITLE
Transdermal Drug Delivery - Technologies, Markets, and Companies Transdermal Drug Delivery - Technologies, Markets, and Companies - Product Thumbnail Image

Transdermal Drug Delivery - Technologies, Markets, and Companies

This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes....

April 2015
FROM

Orally Inhaled Bronchodilators to 2022

Asthma and COPD continue to be a health segments that present significant challenges to patients and the caregiver community. Patient adherence with prescribing instructions and treatment protocols...

April 2015
FROM

Orally Inhaled Corticosteroids to 2022

Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient...

April 2015
FROM

Analysis of the Global Diabetes Drug Delivery Market

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug...

March 2015
FROM

A Product and Pipeline Analysis of the Opioid Therapeutics and Drug Delivery Market

This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage,...

March 2015
FROM

Regulatory Trends in the US Pharma/Biotech Industry

This market insight provides an analysis of the regulatory trends occurring in the US pharma/biotech industry for 2014. Included in this deliverable is an analysis of the new molecular entities (NME)...

February 2015
FROM

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market,...

February 2015
FROM

Subcutaneous Biologics Market, 2015 - 2025

Amongst various efforts to ensure efficient drug delivery, subcutaneous administration has emerged as one of the most promising approaches to deliver viscous biologic drugs in a patient friendly format....

January 2015
FROM

Oral Thin Films Market, 2015 - 2025

Oral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets / capsules to modern-day fast disintegrating and rapidly acting tablets / films, the...

January 2015
FROM

Drug Self-Administration to 2022

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism...

January 2015
FROM

Pen Injectors to 2022

User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery...

January 2015
FROM

Autoinjectors to 2022

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by...

January 2015
FROM

Injectable Drug Delivery to 2022

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several...

January 2015
FROM

Sustained Release Injectables to 2022

The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent...

January 2015
FROM

Prefilled Syringes to 2022

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing...

January 2015
FROM

Subcutaneous Self-Administration Markets to 2022

As healthcare markets continue to evolve, drug developers and their supply chain partners are attempting to keep pace by addressing economic, market and therapeutic factors that increasingly revolve...

December 2014
FROM

Immunity to Helminths and Novel Therapeutic Approaches, Volume 2

This volume covers research on the interaction of major helminth parasites with the immune system. The main focus of the e-book is the ability of helminths to subvert host immune responses, on the one...

December 2014

Global Pulmonary Drug Delivery Systems Market 2015-2019

About Pulmonary Drug Delivery Systems Pulmonary delivery of drugs leads to the deposition of drugs in the lungs and subsequent local or systemic therapeutic activity. The pulmonary route of administration...

November 2014
FROM

Inner Ear Diseases: Novel Drug Delivery Approaches

A significant proportion of the world’s population is suffering from otologic diseases. Absence of any disease modifying drugs is a big unmet need in the market. The current treatment of inner ear diseases...

November 2014
FROM

Insulin Pen Market, Users (Reusable & Prefilled) & Forecast - Worldwide Analysis

In 2013, more than 50 Thousand insulin users opt for an insulin pen. Out of this major percentage of population uses Reusable (Cartridge) insulin pen compared to Prefilled (Disposable) insulin pen....

August 2014
FROM
Loading Indicator

Our Clients

Bayer AG LEO Laboratories Ltd. Grünenthal GmbH Medtronic, Inc. Teva Pharmaceutical Industries Ltd. Pall Corporation